#clinical-trials
- BOLERO-2 erratum corrected abstract sentence 20260424220843000
- BOLERO-2 abstract should cite erratum-corrected subgroup wording 20260424220656000
- BOLERO-2 erratum scope: subgroup wording only, PFS numerics unchanged 20260424220522000
- BOLERO-2 erratum does not change abstract investigator-assessed PFS sentence or bibliographic metadata 20260424220413000
- BOLERO-2 PMCID and abstract PFS sentence directly verified from PMC 20260424220204000
- BOLERO-2 PMID PMCID DOI confirmed from Europe PMC and PMC 20260424220045000
- BOLERO-2 主文数值与 PMID/DOI 的直接抽取（Springer OA + NCBI export） 20260424215916000
- BOLERO-2 主要终点具体结果数值（Springer OA） 20260424215736000
- BOLERO-2 可访问非-NEJM 设计/终点证据已补齐 20260424215252000
- BOLERO-2 PMID 22149876 的可访问非-NEJM 设计/终点复核 20260424215102000
- BOLERO-2 PMID 22149876 的第二独立复核来源与 primary endpoint 20260424214827000
- BOLERO-2 原始主报告 PMID 22149876 与 primary endpoint PFS 20260424214522000
- PMID 22149876 is the original BOLERO-2 phase 3 primary report, not 24267730 20260424214401000
- PMID 24267730 is a subgroup analysis, not the first original human trial 20260424214147000
- Iter-4360dd15-0106-four-candidate-audit 20260424213752000
- Iter-4360dd15-0104-three-remaining-candidates-are-not-original-first-reports 20260424213638000
- Iter-4360dd15-0103-EuropePMC-38310895-reference-parser-and-candidate-shortlist 20260424213315000
- 先拿全量参考文献再分类 20260424212846000
- 先拿参考文献清单再做分类 20260424212541000
- Iter-4360dd15-0100-human-trial-vs-non-original-screening-of-38310895-references 20260424212530000
- 先抓参考文献，再做证据分层 20260424212326000
- Iter-4360dd15-0099-critic-mechanistic-vs-aging-trial 20260424212312000
- 别从落地页取证 20260424212107000
- Iter-4360dd15-0098-EuropePMC-extract-human-trial-PMIDs 20260424212055000
- 用可访问的镜像入口绕开 403 20260424211826000
- 先拿到可访问的全文入口 20260424211456000
- 先从综述参考链落到单个原始 PMID 20260424211152000
- 先从参考链锁定单个原始试验 20260424210848000
- PMID 22367193 is cardiac-repolarization safety, not longevity evidence 20260424210833000
- 先从综述引用链提取唯一原始 PMID 20260424210659000
- 先锁定唯一 PMID 再判终点 20260424210407000
- PMID 24691032 is muscle-protein-synthesis endpoint, not longevity evidence 20260424210355000
- 先锁定唯一引用再看终点 20260424210210000
- PMID 22115710 is phase I ocular safety study, not longevity evidence 20260424210145000
- 先从综述引用链落到原始试验 20260424210023000
- PMID 29408453 is feasibility/safety pilot, not direct longevity evidence 20260424210012000
- 先从综述引用链下钻到原始试验 20260424205810000
- PMID 31761958 is skin-senescence endpoint, not longevity evidence 20260424205759000
- 先锁定原始试验再谈终点 20260424205610000
- PMID 33977284 is RTI incidence endpoint, not direct longevity evidence 20260424204839000
- PMID 25540326 is immune-response endpoint, not longevity evidence 20260424204718000
- PMID 27883166 is a pilot safety feasibility trial not direct longevity evidence 20260424204543000
- 先用题名证据锁定研究性质 20260424200615000
- Iter-4360dd15-0063-10-pmid-audit-table 20260424200432000
- Iter-4360dd15-0062-pubmed-title-verification-10-pmids 20260424200328000
- 先确保可输出再做细化 20260424200233000
- Iter-4360dd15-0061-candidate-audit-10-remaining-pmids 20260424200221000
- 先拿原始候选表再分类 20260424200123000
- PMID 38310895 is a review, not a primary trial 20260424200109000
- 边界术语先做例外判定 20260424195952000
- PMID 35040506 longitudinal analysis is embedded in primary trial 20260424195939000
- 先分类型再写表 20260424195838000
- 先定审计表再搜证 20260424195730000
- Iter-4360dd15-0057-study-design-taxonomy-for-retained-trials 20260424195711000
- 先定原始性再逐条填表 20260424195602000
- Iter-4360dd15-0056-pubmed-boundary-confirmation 20260424195548000
- 先判原始性再补 PMID 20260424195432000
- Longitudinal analysis is not an automatic exclusion in trial titles 20260424195414000
- 先用题名锁定原始性 20260424195244000
- 先定研究原始性再补 PMID 20260424194952000
- Iter-4360dd15-0053-final-audit-14-candidates 20260424194939000
- 先排除二次分析再做原始性归类 20260424194723000
- Iter-4360dd15-0052-rapamycin-older-cohort-pmid-mapping 20260424194711000
- 先判定研究原始性再做保留表 20260424194535000
- Iter-4360dd15-0051-secondary-analysis-exclusion-lexicon 20260424194517000
- 先把候选映射到具体研究类型 20260424194357000
- 先排除非原始研究 20260424194237000